Impact of secondhand smoke exposure in former smokers on their subsequent risk of coronary heart disease: evidence from the population-based cohort of the Tehran Lipid and Glucose Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Cigarette smoking is an established, strong, and modifiable risk factor for coronary heart disease (CHD). However, little research has investigated CHD risk in former smokers who continue to be exposed to others’ cigarette smoke (former & secondhand smokers).METHODS: In the Tehran Lipid and Glucose Study, a prospective population-based cohort (n=20,069) was followed up for a median period of 14.6 years. A subset of 8,050 participants of 30 years of age and older was analyzed, with first CHD events as the study outcome. Participants were categorized as never, former, current, secondhand, and former & secondhand smokers. Data on smoking intensity (cigarette/d) were also collected. A Cox proportional hazards regression model was applied to estimate the risk of CHD, taking into account the main potential confounders.RESULTS: The mean age of participants was 46.10 ±11.38 years, and they experienced 1,118 first CHD events (with most CHD cases in former smokers) during the follow-up period. The risk of CHD was highest in current smokers, followed in order by former & secondhand, former, and secondhand smokers (hazard ratio [HR], 1.99; 95% confidence interval [CI], 1.65 to 2.39; HR, 1.55; 95% CI, 1.15 to 2.08; HR, 1.39; 95% CI, 1.12 to 1.72; HR, 1.27; 95% CI, 1.07 to 1.51, respectively), compared to never smokers. The risk of CHD increased with smoking intensity, which has been proposed as a preferable measure of smoking, indicating a dose-response pattern.CONCLUSIONS: The elevated risk of CHD in former & secondhand smokers was a noteworthy finding, with possible implications for health policy; however, further research is needed.
Abstract
OBJECTIVES: Cigarette smoking is an established, strong, and modifiable risk factor for coronary heart disease (CHD). However, little research has investigated CHD risk in former smokers who continue to be exposed to others’ cigarette smoke (former & secondhand smokers).METHODS: In the Tehran Lipid and Glucose Study, a prospective population-based cohort (n=20,069) was followed up for a median period of 14.6 years. A subset of 8,050 participants of 30 years of age and older was analyzed, with first CHD events as the study outcome. Participants were categorized as never, former, current, secondhand, and former & secondhand smokers. Data on smoking intensity (cigarette/d) were also collected. A Cox proportional hazards regression model was applied to estimate the risk of CHD, taking into account the main potential confounders.RESULTS: The mean age of participants was 46.10 ±11.38 years, and they experienced 1,118 first CHD events (with most CHD cases in former smokers) during the follow-up period. The risk of CHD was highest in current smokers, followed in order by former & secondhand, former, and secondhand smokers (hazard ratio [HR], 1.99; 95% confidence interval [CI], 1.65 to 2.39; HR, 1.55; 95% CI, 1.15 to 2.08; HR, 1.39; 95% CI, 1.12 to 1.72; HR, 1.27; 95% CI, 1.07 to 1.51, respectively), compared to never smokers. The risk of CHD increased with smoking intensity, which has been proposed as a preferable measure of smoking, indicating a dose-response pattern.CONCLUSIONS: The elevated risk of CHD in former & secondhand smokers was a noteworthy finding, with possible implications for health policy; however, further research is needed.
참고문헌 (48)
- GBD 2017 Causes of Death Collaborators, "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1736~1788 (2018)
- Gaziano TA, "Braunwald’s heart disease: a textbook of cardiovascular medicine", pp.1~20 (2015), Saunders
- Heidenreich PA, "Forecasting the future of cardiovascular disease in the United States : a policy statement from the American Heart Association", Circulation, 123, pp.933~944 (2011)
- "Sustainable development knowledge platform"[URL]
- Forouzanfar MH, "Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010", Arch Iran Med, 17, pp.304~320 (2014)
- Sadeghi M, "Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025 : the impact of demographic changes", Iran J Public Health, 46, pp.506~516 (2017)
- "WHO report on the global tobacco epidemic 2019"[URL]
- Ng M, "Smoking prevalence and cigarette consumption in 187 countries, 1980-2012", JAMA, 311, pp.183~192 (2014)
- Hackshaw A, "Low cigarette consumption and risk of coronary heart disease and stroke : meta-analysis of 141 cohort studies in 55 study reports", BMJ, 360, pp.j5855~ (2018)
- Jha P, "21st-century hazards of smoking and benefits of cessation in the United States", N Engl J Med, 368, pp.341~350 (2013)
- The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General, "Office on Smoking and Health", Centers for Disease Control and Prevention, 509~ (2006)
- Benjamin EJ, "Heart disease and stroke statistics-2017 update : a report from the American Heart Association", Circulation, 135, pp.e146~e603 (2017)
- Nakamura K, "Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke : pooled analysis of 10 Japanese cohort studies", Cerebrovasc Dis, 33, pp.480~491 (2012)
- Huxley RR, "Cigarette smoking as a risk factor for coronary heart disease in women compared with men : a systematic review and meta-analysis of prospective cohort studies", Lancet, 378, pp.1297~1305 (2011)
- Oza S, "How many deaths are attributable to smoking in the United States? Comparison of methods for estimating smoking-attributable mortality when smoking prevalence changes", Prev Med, 52, pp.428~433 (2011)
- Mons U, "Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults : meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium", BMJ, 350, pp.h1551~ (2015)
- Nance R, "Smoking intensity(pack", day)is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes, 2017, pp.81, 111~119
- Duncan MS, "Association of smoking cessation with subsequent risk of cardiovascular disease", JAMA, 322, pp.642~650 (2019)
- Azizi F, "Tehran Lipid and Glucose Study(TLGS) : rationale and design", Iran J Endocrinol Metab, 2, pp.77~86 (2000)
- Azizi F, "Cardiovascular risk factors in an Iranian urban population : Tehran Lipid and Glucose Study(phase 1)", Soz Praventivmed, 47, pp.408~426 (2002)
- Khalili D, "Outcomes of a longitudinal population-based cohort study and pragmatic community trial : findings from 20 years of the Tehran Lipid and Glucose Study", Int J Endocrinol Metab, 16(4 Suppl), pp.e84748~ (2018)
- Azizi F, "Prevention of non-communicable disease in a population in nutrition transition : Tehran Lipid and Glucose Study phase II", Trials, 10, pp.5~ (2009)
- Khalili D, "The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran : a 10-year population-based cohort study", PLoS One, 9, pp.e105804~ (2014)
- Mirmiran P, "Performance of different definitions of metabolic syndrome for children and adolescents in a 6-year follow-up : Tehran Lipid and Glucose Study(TLGS)", Diabetes Res Clin Pract, 89, pp.327~333 (2010)
- Myint PK, "Risk factors for first-ever stroke in the EPIC-Norfolk prospective population-based study", Eur J Cardiovasc Prev Rehabil, 15, pp.663~669 (2008)
- Zhang QL, "Association of daily tar and nicotine intake with incident myocardial infarction : results from the population-based MONICA", KORA Augsburg Cohort Study 1984-2002, 2011, pp.11, 273~
- Huxley RR, "Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites : the atherosclerosis risk in communities study", Am J Epidemiol, 175, pp.816~826 (2012)
- Hackshaw A, "Low cigarette consumption and risk of coronary heart disease and stroke : meta-analysis of 141 cohort studies in 55 study reports", BMJ, 360, pp.j5855~ (2018)
- Gellert C, "Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults", Eur J Epidemiol, 28, pp.649~658 (2013)
- Tindle HA, "Lifetime smoking history and risk of lung cancer : results from the Framingham Heart Study", J Natl Cancer Inst, 110, pp.1201~1207 (2018)
- Lv X, "Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure : a systematic review and meta-analysis", Int J Cardiol, 199, pp.106~115 (2015)
- Critchley JA, "Mortality risk reduction associated with smoking cessation in patients with coronary heart disease : a systematic review", JAMA, 290, pp.86~97 (2003)
- Sandhu RK, "Smoking, smoking cessation, and risk of sudden cardiac death in women", Circ Arrhythm Electrophysiol, 5, pp.1091~1097 (2012)
- Cox LA Jr, "Low-dose nonlinear effects of smoking on coronary heart disease risk", Dose Response, 10, pp.219~232 (2012)
- Law MR, "Environmental tobacco smoke exposure and ischaemic heart disease : an evaluation of the evidence", BMJ, 315, pp.973~980 (1997)
- Law MR, "Environmental tobacco smoke and ischemic heart disease", Prog Cardiovasc Dis, 46, pp.31~38 (2003)
- Ambrose JA, "The pathophysiology of cigarette smoking and cardiovascular disease : an update", J Am Coll Cardiol, 43, pp.1731~1737 (2004)
- Rahman MM, "Structural and functional alteration of blood vessels caused by cigarette smoking : an overview of molecular mechanisms", Curr Vasc Pharmacol, 5, pp.276~292 (2007)
- Armani C, "Molecular and biochemical changes of the cardiovascular system due to smoking exposure", Curr Pharm Des, 15, pp.1038~1053 (2009)
- Yamaguchi Y, "Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin", Atherosclerosis, 172, pp.259~265 (2004)
- Yamaguchi Y, "Facilitated nitration and oxidation of LDL in cigarette smokers", Eur J Clin Invest, 35, pp.186~193 (2005)
- Yamaguchi Y, "Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits", Atherosclerosis, 156, pp.109~117 (2001)
- Bermudez EA, "Relation between markers of systemic vascular inflammation and smoking in women", Am J Cardiol, 89, pp.1117~1119 (2002)
- Zhang J, "Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress", Exp Biol Med(Maywood), 227, pp.823~829 (2002)
- Barnoya J, "Cardiovascular effects of secondhand smoke : nearly as large as smoking", Circulation, 111, pp.2684~2698 (2005)
- Kenfield SA, "Smoking and smoking cessation in relation to mortality in women", JAMA, 299, pp.2037~2047 (2008)
- Pope CA, "Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke : shape of the exposure-response relationship", Circulation, 120, pp.941~948 (2009)
- Gellert C, "Smoking and all-cause mortality in older people : systematic review and meta-analysis", Arch Intern Med, 172, pp.837~844 (2012)
